Company intelligence / Profile preview

Merrell

Cincinnati, Ohio, United Statesmerrell.com ↗

Ownership: Private
Employees: ~600
Development stage: Commercial

Overview

Merrell/Merrell Dow developed and marketed several blockbuster drugs including Cardizem (diltiazem) for hypertension and angina; Carafate for ulcers; Seldane for allergies; Nicorette for smoking cessation. Some products were withdrawn or replaced due to safety or patent expiry issues. The company’s portfolio included both prescription and OTC medications with global approvals.

Therapeutic areas: GastroenterologyPsychiatryCardiovascularImmunology
Modalities: Small molecule
Industry: Pharma

Drug pipeline

2 assets

Chlorotrianisene

1 more asset in the full pipeline.

Request access →

Partnerships

Tanabe Seiyaku Co.Gensia PharmaceuticalsImmulogic Pharmaceuticals

Beyond the preview

Go deeper on Merrell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Merrell.

Explore the full profile